1471-0528/asset/BJO_left.gif?v=1&s=0fb87361cdb6be25fdf05019eed6d47f5143f610)
1471-0528/asset/olbannerright.gif?v=1&s=3892ef16ff18d6834c302faf85268a49f5fc588f)
Is postoperative radiotherapy or maintenance chemotherapy necessary for carcinoma of the uterine cervix?
Article first published online: 19 AUG 2005
DOI: 10.1111/j.1471-0528.1988.tb12805.x
Issue
1471-0528/asset/cover.gif?v=1&s=b4e1d96c46e18c61210d584b63c13ee375cf562b "BJOG: An International Journal of Obstetrics & Gynaecology")
BJOG: An International Journal of Obstetrics & Gynaecology
Volume 95, Issue 5, pages 503–506, May 1988
Additional Information
How to Cite
SHIROMIZU, K., MATSUZAWA, M., TAKAHASHI, M. and ISHIHARA, O. A. (1988), Is postoperative radiotherapy or maintenance chemotherapy necessary for carcinoma of the uterine cervix?. BJOG: An International Journal of Obstetrics & Gynaecology, 95: 503–506. doi: 10.1111/j.1471-0528.1988.tb12805.x
Publication History
- Issue published online: 19 AUG 2005
- Article first published online: 19 AUG 2005
- Received 18 May 1987, Accepted 18 August 1987
- Abstract
- References
- Cited By
Summary. The effectiveness of postoperative radiotherapy and adjuvant chemotherapy was examined for patients with uterine cervical squamous cell carcinoma. Whole pelvis irradiation is unnecessary for patients with less than 2/3 of depth of cervical local involvement without pelvic regional lymph node metastases. Adjuvant chemotherapy with tegafur [l-(2-tetrahydrofuryl)-5-fluorouracil] (600 mg/day) has failed to improve the survival of patients with positive lymph node metastases.